Literature DB >> 23102802

Topical tacrolimus with custom trays in the treatment of severe oral chronic graft-versus-host disease refractory to a potent topical steroid therapy: a case report.

Ronald S Brown1, Dean Edwards, Tracey Walsh-Chocolaad, Richard W Childs.   

Abstract

BACKGROUND: The authors present a case demonstrating the success of topical tacrolimus (TAC) therapy with custom trays in the treatment of oral chronic graft-versus-host disease (cGVHD). The 41-year-old male patient initially responded to topical steroid therapy (clobetasol propionate 0.05% ointment) applied both topically and with flexible carrier trays, but later became refractory to this potent topical agent. Topical TAC therapy with flexible carrier trays and systemic prednisone therapy was initiated.
RESULTS: The patient responded favorably with the change to topical TAC therapy with custom trays (and oral prednisone). His oral cGVHD lesions resolved within a period of 4 weeks. The improvement has remained stable at 14 months of follow-up. CLINICAL IMPLICATIONS: This is the first case reported with regard to the successful resolution of steroid recalcitrant cGVHD successfully treated with topical TAC with custom trays.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23102802      PMCID: PMC3596449          DOI: 10.1016/j.oooo.2012.07.487

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  24 in total

Review 1.  Oral lichen planus: update on etiopathogenesis, diagnosis and treatment.

Authors:  Vito Crincoli; Maria Beatrice Di Bisceglie; Michele Scivetti; Alberta Lucchese; Simona Tecco; Felice Festa
Journal:  Immunopharmacol Immunotoxicol       Date:  2010-07-06       Impact factor: 2.730

Review 2.  Topical immunomodulators for management of oral mucosal conditions, a systematic review; part I: calcineurin inhibitors.

Authors:  Sharon Elad; Joel B Epstein; Noam Yarom; Scott Drucker; Rinat Tzach; Inger von Bültzingslöwen
Journal:  Expert Opin Emerg Drugs       Date:  2010-12       Impact factor: 4.191

Review 3.  Topical tacrolimus and pimecrolimus in the treatment of oral lichen planus: an update.

Authors:  Pía López-Jornet; Fabio Camacho-Alonso; Noemi Salazar-Sanchez
Journal:  J Oral Pathol Med       Date:  2009-11-20       Impact factor: 4.253

4.  Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome.

Authors:  A Allen; E Siegfried; R Silverman; M L Williams; P M Elias; S K Szabo; N J Korman
Journal:  Arch Dermatol       Date:  2001-06

5.  Squamous cell carcinoma in a patient with oral lichen planus treated with topical application of tacrolimus.

Authors:  Ulf Mattsson; Bengt Magnusson; Mats Jontell
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2010-07

Review 6.  Management of drug and food interactions with azole antifungal agents in transplant recipients.

Authors:  Elizabeth Dodds-Ashley
Journal:  Pharmacotherapy       Date:  2010-08       Impact factor: 4.705

7.  Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group.

Authors:  S Reitamo; A Wollenberg; E Schöpf; J L Perrot; R Marks; T Ruzicka; E Christophers; A Kapp; M Lahfa; A Rubins; S Jablonska; M Rustin
Journal:  Arch Dermatol       Date:  2000-08

8.  Combined topical dexamethasone/tacrolimus therapy for management of oral chronic GVHD.

Authors:  H Mawardi; K Stevenson; B Gokani; R Soiffer; N Treister
Journal:  Bone Marrow Transplant       Date:  2009-11-02       Impact factor: 5.483

9.  [Gran versus host disease with oral involvement: report of one case].

Authors:  Gonzalo Rojas A; Néstor González G; Cristián Venables G; Daniel Araos H
Journal:  Rev Med Chil       Date:  2009-03-23       Impact factor: 0.553

Review 10.  Long-term safety of tacrolimus ointment in atopic dermatitis.

Authors:  Anita Remitz; Sakari Reitamo
Journal:  Expert Opin Drug Saf       Date:  2009-07       Impact factor: 4.250

View more
  4 in total

1.  Clinical approach in the management of oral chronic graft-versus-host disease (cGVHD) in a series of specialized medical centers.

Authors:  Sharon Elad; Siri Beier Jensen; Judith E Raber-Durlacher; Nancy Mouradian; Elvira M P Correa; Mark M Schubert; Nicole M A Blijlevens; Joel B Epstein; Deborah P Saunders; Tuomas Waltimo; Noam Yarom; Yehuda Zadik; Michael T Brennan
Journal:  Support Care Cancer       Date:  2014-11-23       Impact factor: 3.603

2.  Comparison of the Efficacy of Topical Triamcinolone in Orabase and Curcumin in Orabase in Oral Graft-Versus-Host Disease.

Authors:  Arash Mansourian; Babak Bahar; Mahdieh Sadat Moosavi; Massoud Amanlou; Shahabodin Babaeifard
Journal:  J Dent (Tehran)       Date:  2017-11

Review 3.  Oral Graft-Versus-Host Disease: A Pictorial Review and a Guide for Dental Practitioners.

Authors:  Sharon Elad; Omar Aljitawi; Yehuda Zadik
Journal:  Int Dent J       Date:  2021-01-12       Impact factor: 2.607

Review 4.  Management of oral Graft versus Host Disease with topical agents: A systematic review.

Authors:  Rui Albuquerque; Zahid Khan; Ana Poveda; Jonathan Higham; Andrea Richards; Luis Monteiro; Enric Jané-Salas; José Lopez-Lopez; Saman Warnakulasuriya
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2016-01-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.